UEEC
United Health Products, Inc.
Price Chart
Latest Quote
$0.06
-0.00 (-8.33%)
Current Price
| Previous Close | $0.06 |
| Open | $0.06 |
| Day High | $0.06 |
| Day Low | $0.06 |
| Volume | 50,000 |
Stock Information
| Shares Outstanding | 260.39M |
| Total Debt | $2.06M |
| Cash Equivalents | $1K |
| Net Income | $-1.45M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $14.32M |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $16.38M |
| Income | $-1.45M |
| Cash/sh | $0.00 |
Financial Ratios
| Current Ratio | 0.01 |
Returns & Margins
| ROA | -365.00% |
Ownership
| Insider Ownership | 7.91% |
| Institutional Ownership | 0.06% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.06 |
| SMA50 | $0.06 |
| SMA200 | $0.06 |
| RSI | 36.73 |
| ATR | 0.0076 |
| Shares Float | 231.17M |
| Rel Volume | 0.30 |
Performance History
| Week | -15.38% |
| Month | -19.12% |
| Quarter | +0.00% |
| 6 Months | -1.79% |
| YTD | +0.00% |
| Year | -71.79% |
| 3 Years | -69.61% |
| 5 Years | -94.47% |
| 10 Years | -46.60% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-04 | $0.05 | 50,000 |
| 2026-06-03 | $0.06 | 295,200 |
| 2026-06-02 | $0.06 | 140,200 |
| 2026-06-01 | $0.05 | 348,000 |
| 2026-05-29 | $0.06 | 48,300 |
| 2026-05-28 | $0.06 | 102,000 |
| 2026-05-27 | $0.06 | 178,400 |
| 2026-05-26 | $0.06 | 136,500 |
| 2026-05-22 | $0.05 | 249,100 |
| 2026-05-21 | $0.05 | 35,000 |
| 2026-05-20 | $0.05 | 431,000 |
| 2026-05-19 | $0.06 | 220,500 |
| 2026-05-18 | $0.06 | 597,400 |
| 2026-05-15 | $0.06 | 27,700 |
| 2026-05-14 | $0.07 | 21,800 |
| 2026-05-13 | $0.06 | 30,500 |
| 2026-05-12 | $0.06 | 23,200 |
| 2026-05-11 | $0.06 | 330,800 |
| 2026-05-08 | $0.07 | 63,700 |
| 2026-05-07 | $0.07 | 2,500 |
| 2026-05-06 | $0.07 | 160,800 |
| 2026-05-05 | $0.07 | 573,400 |
About United Health Products, Inc.
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers CelluSTAT hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. The company was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.
đ° Latest News
No news articles available at the moment. Check back later for updates on UEEC.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $37,500 | $59 |
| Operating Revenue | $0 | $0 | $37,500 | $59 |
| Reconciled Cost Of Revenue | - | $0 | $18,644 | $25 |
| Cost Of Revenue | - | $0 | $18,644 | $25 |
| Expenses | ||||
| Interest Expense | $109,246 | $116,196 | $78,845 | $618,251 |
| Total Expenses | $2,007,572 | $2,426,539 | $2,839,539 | $29,800,694 |
| Other Income Expense | $115,085 | $-80,532 | $1,193,383 | $-130,297 |
| Net Non Operating Interest Income Expense | $-109,246 | $-116,196 | $-78,845 | $-618,251 |
| Interest Expense Non Operating | $109,246 | $116,196 | $78,845 | $618,251 |
| Operating Expense | $2,007,572 | $2,426,539 | $2,820,895 | $29,800,669 |
| Other Non Operating Income Expenses | - | - | $1,402,981 | $304,273 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-2,001,733 | $-2,623,267 | $-1,687,501 | $-30,549,183 |
| Net Interest Income | $-109,246 | $-116,196 | $-78,845 | $-618,251 |
| Normalized Income | $-2,116,818 | $-2,542,735 | $-1,477,903 | $-30,114,613 |
| Net Income From Continuing And Discontinued Operation | $-2,001,733 | $-2,623,267 | $-1,687,501 | $-30,549,183 |
| Total Operating Income As Reported | $-2,007,572 | $-2,426,539 | $-2,802,039 | $-29,800,635 |
| Net Income Common Stockholders | $-2,001,733 | $-2,623,267 | $-1,687,501 | $-30,549,183 |
| Net Income | $-2,001,733 | $-2,623,267 | $-1,687,501 | $-30,549,183 |
| Net Income Including Noncontrolling Interests | $-2,001,733 | $-2,623,267 | $-1,687,501 | $-30,549,183 |
| Net Income Continuous Operations | $-2,001,733 | $-2,623,267 | $-1,687,501 | $-30,549,183 |
| Pretax Income | $-2,001,733 | $-2,623,267 | $-1,687,501 | $-30,549,183 |
| Special Income Charges | $115,085 | $-80,532 | $-209,598 | $-434,570 |
| Operating Income | $-2,007,572 | $-2,426,539 | $-2,802,039 | $-29,800,635 |
| Gross Profit | - | $0 | $18,856 | $34 |
| Per Share | ||||
| Diluted EPS | $-0.01 | $-0.01 | $-0.01 | $-0.14 |
| Basic EPS | $-0.01 | $-0.01 | $-0.01 | $-0.14 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,002,936 | $-2,421,682 | $-1,395,008 | $-29,496,362 |
| Total Unusual Items | $115,085 | $-80,532 | $-209,598 | $-434,570 |
| Total Unusual Items Excluding Goodwill | $115,085 | $-80,532 | $-209,598 | $-434,570 |
| Reconciled Depreciation | $4,636 | $4,857 | $4,050 | $0 |
| EBITDA (Bullshit earnings) | $-1,887,851 | $-2,502,214 | $-1,604,606 | $-29,930,932 |
| EBIT | $-1,892,487 | $-2,507,071 | $-1,608,656 | $-29,930,932 |
| Diluted Average Shares | $248,173,249 | $239,080,282 | $229,718,142 | $225,741,684 |
| Basic Average Shares | $248,173,249 | $239,080,282 | $229,718,142 | $225,741,684 |
| Diluted NI Availto Com Stockholders | $-2,001,733 | $-2,623,267 | $-1,687,501 | $-30,549,183 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Other Special Charges | $-115,085 | $80,532 | $209,598 | $434,570 |
| Research And Development | $355,936 | $598,810 | $624,564 | $237,458 |
| Selling General And Administration | $1,651,636 | $1,827,729 | $2,196,331 | $29,563,211 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-2,472,181 | $-1,746,626 | $-2,101,377 | $-1,141,894 |
| Total Assets | $269,979 | $284,643 | $350,528 | $26,799 |
| Total Non Current Assets | $78,296 | $132,821 | $279,489 | $0 |
| Non Current Prepaid Assets | $2,850 | $2,850 | $0 | - |
| Non Current Deferred Assets | $0 | $21,051 | $243,039 | $0 |
| Goodwill And Other Intangible Assets | $28,350 | $32,400 | $36,450 | $0 |
| Other Intangible Assets | $28,350 | $32,400 | $36,450 | - |
| Current Assets | $191,683 | $151,822 | $71,039 | $26,799 |
| Other Current Assets | $22,800 | $22,804 | $22,932 | $5,000 |
| Inventory | $0 | $33,598 | $34,730 | $0 |
| Cash Cash Equivalents And Short Term Investments | $168,883 | $95,420 | $13,377 | $21,799 |
| Cash And Cash Equivalents | $168,883 | $95,420 | $13,377 | $21,799 |
| Cash Financial | $168,883 | $95,420 | $13,377 | $21,799 |
| Prepaid Assets | - | - | - | $5,000 |
| Debt | ||||
| Net Debt | $888,617 | $612,080 | $674,267 | $197,201 |
| Total Debt | $1,105,989 | $784,827 | $687,644 | $219,000 |
| Long Term Debt And Capital Lease Obligation | $1,072,658 | $48,489 | $0 | - |
| Long Term Debt | $1,057,500 | - | - | - |
| Current Debt And Capital Lease Obligation | $33,331 | $736,338 | $687,644 | $219,000 |
| Current Debt | - | $707,500 | $687,644 | $219,000 |
| Other Current Borrowings | - | $707,500 | $678,508 | $219,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,713,810 | $1,998,869 | $2,415,455 | $1,168,693 |
| Total Non Current Liabilities Net Minority Interest | $1,072,658 | $48,489 | $0 | $0 |
| Current Liabilities | $1,641,152 | $1,950,380 | $2,415,455 | $1,168,693 |
| Payables And Accrued Expenses | $999,321 | $961,292 | $1,727,811 | $949,693 |
| Payables | $830,672 | $869,567 | $1,255,232 | $826,486 |
| Accounts Payable | $830,672 | $869,567 | $1,255,232 | $826,486 |
| Current Notes Payable | - | $0 | $9,136 | $0 |
| Equity | ||||
| Common Stock Equity | $-2,443,831 | $-1,714,226 | $-2,064,927 | $-1,141,894 |
| Total Equity Gross Minority Interest | $-2,443,831 | $-1,714,226 | $-2,064,927 | $-1,141,894 |
| Stockholders Equity | $-2,443,831 | $-1,714,226 | $-2,064,927 | $-1,141,894 |
| Retained Earnings | $-78,700,943 | $-76,699,210 | $-74,075,943 | $-72,388,442 |
| Other Equity Interest | - | - | $-50,550 | - |
| Other | ||||
| Ordinary Shares Number | $252,408,222 | $244,783,222 | $230,871,034 | $228,667,229 |
| Share Issued | $252,408,222 | $244,783,222 | $230,871,034 | $228,667,229 |
| Tangible Book Value | $-2,472,181 | $-1,746,626 | $-2,101,377 | $-1,141,894 |
| Invested Capital | $-1,386,331 | $-1,006,726 | $-1,377,283 | $-922,894 |
| Working Capital | $-1,449,469 | $-1,798,558 | $-2,344,416 | $-1,141,894 |
| Capital Lease Obligations | $48,489 | $77,327 | $0 | - |
| Total Capitalization | $-1,386,331 | $-1,714,226 | $-2,064,927 | $-1,141,894 |
| Additional Paid In Capital | $76,004,704 | $74,740,201 | $71,830,695 | $71,017,881 |
| Capital Stock | $252,408 | $244,783 | $230,871 | $228,667 |
| Common Stock | $252,408 | $244,783 | $230,871 | $228,667 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $15,158 | $48,489 | $0 | - |
| Current Capital Lease Obligation | $33,331 | $28,838 | $0 | - |
| Pensionand Other Post Retirement Benefit Plans Current | $608,500 | $252,750 | - | - |
| Current Accrued Expenses | $168,649 | $91,725 | $472,579 | $123,207 |
| Net PPE | $47,096 | $76,520 | $0 | $0 |
| Gross PPE | $47,096 | $76,520 | $0 | $0 |
| Other Properties | $47,096 | $76,520 | - | - |
| Finished Goods | $0 | $33,598 | $34,730 | $0 |
| Raw Materials | $0 | $0 | $0 | $0 |
| Accumulated Depreciation | - | - | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,194,716 | $-2,200,645 | $-660,220 | $-828,079 |
| Operating Activities | ||||
| Operating Cash Flow | $-1,194,716 | $-2,200,645 | $-619,720 | $-828,079 |
| Cash Flow From Continuing Operating Activities | $-1,194,716 | $-2,200,645 | $-619,720 | $-828,079 |
| Operating Gains Losses | $-115,085 | $80,532 | $209,598 | $434,570 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $-2,850 | $-40,500 | $0 |
| Cash Flow From Continuing Investing Activities | $0 | $-2,850 | $-40,500 | $0 |
| Net Other Investing Changes | - | $-2,850 | - | - |
| Capital Expenditure | - | - | $-40,500 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $929,579 | $2,326,074 | $175,887 | $479,802 |
| Financing Cash Flow | $1,268,179 | $2,285,538 | $651,798 | $803,802 |
| Cash Flow From Continuing Financing Activities | $1,268,179 | $2,285,538 | $651,798 | $803,802 |
| Net Other Financing Charges | $-11,400 | $-17,400 | $-26,200 | $209,000 |
| Net Common Stock Issuance | $929,579 | $2,326,074 | $125,887 | $479,802 |
| Common Stock Issuance | $929,579 | $2,326,074 | $175,887 | $479,802 |
| Repurchase Of Capital Stock | - | $0 | $-50,000 | $0 |
| Other | ||||
| Repayment Of Debt | $0 | $-23,136 | $-317,139 | $-36,500 |
| Issuance Of Debt | $350,000 | $0 | $869,250 | $360,500 |
| Interest Paid Supplemental Data | $0 | $703 | $12,871 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $168,883 | $95,420 | $13,377 | $21,799 |
| Beginning Cash Position | $95,420 | $13,377 | $21,799 | $46,076 |
| Changes In Cash | $73,463 | $82,043 | $-8,422 | $-24,277 |
| Net Issuance Payments Of Debt | $350,000 | $-23,136 | $552,111 | $324,000 |
| Net Long Term Debt Issuance | $350,000 | $-23,136 | - | $115,000 |
| Long Term Debt Payments | $0 | $-23,136 | - | - |
| Long Term Debt Issuance | $350,000 | $0 | - | $115,000 |
| Change In Working Capital | $508,868 | $-158,259 | $1,162,931 | $1,333,728 |
| Change In Payables And Accrued Expense | $508,864 | $-159,519 | $1,215,593 | $1,338,703 |
| Change In Accrued Expense | $432,674 | $146 | $576,872 | $645,011 |
| Change In Payable | $76,190 | $-159,665 | $638,721 | $693,692 |
| Change In Account Payable | $76,190 | $-159,665 | $638,721 | $693,692 |
| Change In Prepaid Assets | $4 | $128 | $-17,932 | $-5,000 |
| Change In Inventory | $0 | $1,132 | $-34,730 | $25 |
| Stock Based Compensation | $375,000 | $0 | $-325,331 | $26,861,097 |
| Asset Impairment Charge | $33,598 | $0 | $0 | $170,999 |
| Depreciation Amortization Depletion | $4,636 | $4,857 | $4,050 | $0 |
| Depreciation And Amortization | $4,636 | $4,857 | $4,050 | $0 |
| Amortization Cash Flow | $4,050 | $4,050 | $4,050 | $0 |
| Amortization Of Intangibles | $4,050 | $4,050 | $4,050 | $0 |
| Depreciation | $586 | $807 | $0 | - |
| Net Income From Continuing Operations | $-2,001,733 | $-2,623,267 | $-1,687,501 | $-30,549,183 |
| Common Stock Payments | - | $0 | $-50,000 | $0 |
| Net Short Term Debt Issuance | - | $-23,136 | $552,111 | $324,000 |
| Short Term Debt Payments | - | $-23,136 | $-317,139 | $-36,500 |
| Short Term Debt Issuance | - | $0 | $869,250 | $360,500 |
| Net Investment Purchase And Sale | - | $-2,850 | $0 | - |
| Purchase Of Investment | - | $-2,850 | $0 | - |
| Net Intangibles Purchase And Sale | - | $0 | $-40,500 | $0 |
| Purchase Of Intangibles | - | $0 | $-40,500 | $0 |
| Other Non Cash Items | - | $495,492 | $16,533 | $920,710 |
| Net PPE Purchase And Sale | - | - | - | $0 |
| Purchase Of PPE | - | - | - | $0 |
Fetched: 2026-02-02